{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:24:27Z","timestamp":1787574267316,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Institutes of T\u00fcrkiye","award":["37871"],"award-info":[{"award-number":["37871"]}]},{"award":["37871"],"award-info":[{"award-number":["37871"]}],"id":[{"id":"https:\/\/ror.org\/01d6ka036","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Cyclin-dependent kinase (CDK) inhibitors are promising therapeutic agents for neuroblastoma, particularly in MYCN-amplified tumors; however, the molecular responses associated with CDK inhibition remain incompletely understood. MYCN-amplified BE(2)-C and MYCN-non-amplified SH-SY5Y neuroblastoma cells were treated with Abemaciclib or Arcyriaflavin A. Drug responses were evaluated using MTT, Annexin V ELISA, wound healing, colony formation, quantitative real-time PCR, and Western blot analyses. Exploratory transcriptomic profiling was performed by RNA sequencing. Because only one biological replicate was available per condition, transcriptomic analyses were limited to descriptive expression trends and pathway-oriented interpretation rather than statistical differential expression analysis. Both inhibitors reduced cell viability in a dose- and time-dependent manner, with BE(2)-C cells showing greater sensitivity than SH-SY5Y cells. Treatment also increased Annexin V levels, reduced wound closure, impaired clonogenic growth, and decreased CDK4\/CDK6 expression, as confirmed by qRT-PCR and Western blotting. Exploratory transcriptomic profiling identified concordant expression trends in genes associated with cell-cycle regulation, DNA replication, and mitotic progression, with broader pathway modulation observed in MYCN-amplified cells. Overall, CDK inhibition suppresses proliferation-associated phenotypes in neuroblastoma and is accompanied by exploratory transcriptomic changes that identify candidate pathways for future validation and mechanistic investigation of MYCN-associated therapeutic responses.<\/jats:p>","DOI":"10.3390\/ijms27167349","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:35:08Z","timestamp":1786984508000},"page":"7349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Functional Effects of Abemaciclib and Arcyriaflavin A in MYCN-Amplified and Non-Amplified Neuroblastoma Cells: An Exploratory Transcriptomic Study"],"prefix":"10.3390","volume":"27","author":[{"given":"Burcu","family":"\u00c7er\u00e7i","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Izmir Katip Celebi University, Cigli, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice \u0130layhan","family":"Karahan","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Izmir Katip Celebi University, Cigli, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-6463","authenticated-orcid":false,"given":"Mustafa","family":"Soy\u00f6z","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Izmir Katip Celebi University, Cigli, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"Pehlivan","sequence":"additional","affiliation":[{"name":"Vocational School of Health Services, Izmir Katip Celebi University, Cigli, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"Pirim","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Izmir Katip Celebi University, Cigli, Izmir 35620, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41588-018-0131-y","article-title":"Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer","volume":"50","author":"Karlsson","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Blavier, L., Yang, R.M., and DeClerck, Y.A. (2020). The tumor microenvironment in neuroblastoma: New players, new mechanisms of interaction and new perspectives. Cancers, 12.","DOI":"10.3390\/cancers12102912"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chen, Y., Yang, H., Xiao, L., Yan, N., and Zhang, M. (2025). Molecular regulation and therapeutic targeting of MYCN in neuroblastoma: A comprehensive review. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1683331"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"De Rosa, P., Severi, F., Zadran, S.K., Russo, M., Aloisi, S., Rigamonti, A., Capranico, G., Milazzo, G., and Perini, G. (2023). MYCN amplification, along with wild-type RB1 expression, enhances CDK4\/6 inhibitors\u2019 efficacy in neuroblastoma cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065408"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.molmed.2025.04.001","article-title":"The RB protein: More than a sentry of cell cycle entry","volume":"31","author":"Thangavelu","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1038\/s41598-022-20769-5","article-title":"CDK4\/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1\/S transition","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-024-03174-2","article-title":"Transcriptional regulation by MYC: An emerging new model","volume":"44","author":"Jakobsen","year":"2025","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gao, T., Sun, Y., Leng, P., Liu, D., Guo, Q., and Li, J. (2025). CDK4\/6 inhibitors in breast cancer therapy: Mechanisms of drug resistance and strategies for treatment. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1549520"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, H.L., Dong, L.L., Jin, M.J., Li, Q.Y., Wang, X., Jia, M.Q., Song, J., Zhang, S.Y., and Yuan, S. (2023). A review of the regulatory mechanisms of N-myc on cell cycle. Molecules, 28.","DOI":"10.3390\/molecules28031141"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12935-025-03675-4","article-title":"Arcyriaflavin A, a cyclin D1\/CDK4 inhibitor, suppresses tumor growth, migration, and invasion of metastatic melanoma cells","volume":"25","author":"Kim","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Han, J.M., and Jung, H.J. (2022). Synergistic anticancer effect of a combination of berbamine and arcyriaflavin A against glioblastoma stem-like cells. Molecules, 27.","DOI":"10.3390\/molecules27227968"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126062","DOI":"10.1016\/j.ijpharm.2025.126062","article-title":"Electrospun membranes from natural polymers with Quercetin: Design and characterization, antioxidant and antimicrobial activity, and potential for skin reinnervation in chronic wounds","volume":"683","author":"Correia","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e70760","DOI":"10.1096\/fj.202501315","article-title":"Antiproliferative and Apoptotic Effects of Mono\/Combined Treatment of Abemaciclib and Regulation of Neuroblastoma-Related miRNAs","volume":"39","author":"Pehlivan","year":"2025","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1007\/s43032-025-01917-4","article-title":"Transcriptomic Profiling Reveals Potential Genes Involved in the Immune Landscape of Polycystic Ovary Syndrome: An Exploratory Study","volume":"32","author":"Zhang","year":"2025","journal-title":"Reprod. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12935-022-02747-z","article-title":"A review on the role of cyclin dependent kinases in cancers","volume":"22","author":"Khoshbakht","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41420-025-02637-z","article-title":"CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid\u2014A promising combination strategy for therapeutic intervention","volume":"11","author":"Shokraie","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4161\/cc.24091","article-title":"CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage","volume":"12","author":"Gogolin","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"pkad045","DOI":"10.1093\/jncics\/pkad045","article-title":"Cyclin-dependent kinase 4 and 6 (CDK4\/6) inhibitors: Existing and emerging differences","volume":"7","author":"Johnston","year":"2023","journal-title":"JNCI Cancer Spectr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1535-7163.MCT-16-0300","article-title":"Spectrum and degree of CDK drug interactions predicts clinical performance","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1158\/1541-7786.MCR-17-0468","article-title":"Competitive kinase enrichment proteomics reveals that abemaciclib inhibits GSK3\u03b2 and activates WNT signaling","volume":"16","author":"Cousins","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF01956468","article-title":"Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian, Eudistoma sp.","volume":"50","author":"Horton","year":"1994","journal-title":"Experientia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/S0960-894X(03)00791-1","article-title":"Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1\u2013CDK4 inhibitors","volume":"13","author":"Shih","year":"2003","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-025-00110-1","article-title":"Phosphatidylserine exposure and plasma membrane perforation as ferroptotic signatures for in vivo imaging","volume":"3","author":"Sonay","year":"2025","journal-title":"npj Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.21037\/tp-2025-142","article-title":"Novel endoplasmic reticulum stress-related gene signature unveils CDKN3 as a prognosticator in neuroblastoma","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Loftus, L.V., Amend, S.R., and Pienta, K.J. (2022). Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094723"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Guo, R., Wang, Y., Zhang, A., Jirawatnotai, S., Chu, C., and Liu, L. (2026). Cyclin D1\/D2\u2013CDK4 Drives Cell Migration by Orchestrating Cytoskeletal Dynamics Through a TGF\u03b2\u2013FAK\u2013Rac1 Axis. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031228"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"114667","DOI":"10.1016\/j.biopha.2023.114667","article-title":"The study of a novel CDK8 inhibitor E966-0530\u201345418 that inhibits prostate cancer metastasis in vitro and in vivo","volume":"162","author":"Ho","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3892\/ijmm.2025.5564","article-title":"The regulatory role of CDK4\/6 inhibitors in tumor immunity and the potential value of tumor immunotherapy (Review)","volume":"56","author":"He","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Remer, E., Badarni, M., Hikri, E., Dayan, A., Levi, L., Popovtzer, A., Iraqi, M., Porgador, A., Joshua, B.Z., and Bachar, G. (2020). CDK 4\/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3K\u03b1 Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103214"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10555-025-10307-w","article-title":"Alternate actions of CDK4\/6 inhibitors beyond cell cycle blockade: Unexplored roles in therapy resistance","volume":"44","author":"Scordamaglia","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2413089121","DOI":"10.1073\/pnas.2413089121","article-title":"The Mitotic Checkpoint Complex controls the association of Cdc20 regulatory protein with the ubiquitin ligase APC\/C in mitosis","volume":"121","author":"Hershko","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1096\/fj.11-185033","article-title":"MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas","volume":"25","author":"Huang","year":"2011","journal-title":"FASEB J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"125644","DOI":"10.1016\/j.ijpharm.2025.125644","article-title":"Fabrication of tolmetin\/cyclodextrin nanofibers for potential wound healing applications: Physicochemical, in vitro characterization, and scratch assay","volume":"677","author":"Siva","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2015.07.055","article-title":"Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells","volume":"493","author":"Botto","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30159","DOI":"10.1074\/jbc.M203566200","article-title":"A novel single amino acid deletion caspase-8 mutant in cancer cells that lost proapoptotic activity","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101471","DOI":"10.1016\/j.trim.2021.101471","article-title":"The changes in the expression levels of \u03b2-catenin gene in pre-and post-Kidney Transplants","volume":"69","author":"Pehlivan","year":"2021","journal-title":"Transpl. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7349\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:35Z","timestamp":1787572055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":36,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167349"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167349","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}